NCH2.DENCH2.DEXETRA
Loading
| Metric | Sep 21 | Sep 22 | Sep 23 |
|---|---|---|---|
| Revenue | 319 | 383 | 653 |
| Gross Profit | 69 | 71 | 95 |
| Operating Income | 27 | 9 | 24 |
| Net Income | 21 | 6 | 23 |
| EBITDA | 31 | 15 | 42 |
| EPS Diluted | 0.17 | 0.05 | 0.21 |
| Metric | Sep 21 | Sep 22 | Sep 23 |
|---|---|---|---|
| Cash & Equivalents | 12 | 27 | 767 |
| Total Current Assets | 341 | 462 | 1,058 |
| Total Assets | 416 | 541 | 1,145 |
| Total Current Liabilities | 191 | 312 | 378 |
| Total Liabilities | 212 | 330 | 400 |
| Total Equity | 203 | 211 | 745 |
| Total Debt | 4 | 4 | 5 |
| Net Debt | -8 | -23 | -762 |
| Metric | Sep 21 | Sep 22 | Sep 23 |
|---|---|---|---|
| Operating Cash Flow | 37 | 87 | -14 |
| Capital Expenditure | -0 | -1 | -4 |
| Free Cash Flow | 36 | 86 | -18 |
| Stock-Based Comp | 0 | 0 | 1 |
| Net Change in Cash | 6 | 16 | 740 |